Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cantor Fitzgerald Maintains Overweight on Braze, Raises Price Target to $38

Author: Benzinga Newsdesk | September 05, 2025 09:41am
Cantor Fitzgerald analyst Matthew Vanvliet maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $35 to $38.

Posted In: BRZE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist